HomeCompareNUGX vs NNN

NUGX vs NNN: Dividend Comparison 2026

NUGX yields 2000000.00% · NNN yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NUGX wins by $4.879226400974806e+39M in total portfolio value
10 years
NUGX
NUGX
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full NUGX calculator →
NNN
NNN REIT Inc.
● Live price
5.28%
Share price
$42.80
Annual div
$2.26
5Y div CAGR
2.8%
Payout ratio
71%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.7K
Annual income
$1,147.75
Full NNN calculator →

Portfolio growth — NUGX vs NNN

📍 NUGX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNUGXNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NUGX + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NUGX pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NUGX
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
NNN
Annual income on $10K today (after 15% tax)
$448.83/yr
After 10yr DRIP, annual income (after tax)
$975.59/yr
At 15% tax rate, NUGX beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NUGX + NNN for your $10,000?

NUGX: 50%NNN: 50%
100% NNN50/50100% NUGX
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

NUGX
No analyst data
Altman Z
-17.6
Piotroski
2/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+5.0% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NUGX buys
0
NNN buys
0
No recent congressional trades found for NUGX or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNUGXNNN
Forward yield2000000.00%5.28%
Annual dividend / share$2.00$2.26
Payout ratio50%71%
1-year div growth0%2.7%
5-year div CAGR0%2.8%
Portfolio after 10y$4.879226400974806e+39M$19.7K
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$1,147.75
Total dividends collected$4.879195005460081e+39M$8.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: NUGX vs NNN ($10,000, DRIP)

YearNUGX PortfolioNUGX Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$200,010,700$200,000,000.00$10,663$542.82+$200.00MNUGX
2$3,738,731,768,458$3,738,517,757,009.35$11,379$587.95+$3738731.76MNUGX
3$65,315,062,866,930,490$65,311,062,423,938,240.00$12,153$637.35+$65315062866.92MNUGX
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$12,990$691.46+$1066400830062625.00MNUGX
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$13,897$750.78+$16272182796453826560.00MNUGX
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$14,879$815.88+$2.3205424011366188e+23MNUGX
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$15,945$887.39+$3.0927990661046884e+27MNUGX
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$17,102$965.99+$3.8524105697352695e+31MNUGX
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$18,360$1,052.49+$4.484688260147987e+35MNUGX
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$19,728$1,147.75+$4.879226400974806e+39MNUGX

NUGX vs NNN: Complete Analysis 2026

NUGXStock

NuGenerex Immuno-Oncology, Inc., an oncology company, focuses on the modulation of the immune system to treat cancer. The company is developing immunotherapeutic products and vaccines. It is developing AE37, a peptide immunotherapeutic vaccine, which is in Phase II clinical trials for the treatment of metastatic triple negative breast cancer. The company was formerly known as Antigen Express, Inc. The company was founded in 1993 and is based in Miramar, Florida. NuGenerex Immuno-Oncology, Inc.is a subsidiary of Generex Biotechnology Corporation.

Full NUGX Calculator →

NNNREIT

NNN REIT (formerly National Retail Properties) is a Dividend King with 34+ consecutive years of dividend increases — one of only three REITs to achieve this status. Focuses on single-tenant properties with long-term net leases to operators in necessity-based retail sectors.

Full NNN Calculator →
📬

Get this NUGX vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NUGX vs SCHDNUGX vs JEPINUGX vs ONUGX vs KONUGX vs MAINNUGX vs ADCNUGX vs EPRTNUGX vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.